GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biovica International AB (OSTO:BIOVIC B) » Definitions » Operating Margin %

Biovica International AB (OSTO:BIOVIC B) Operating Margin % : -2,597.12% (As of Jan. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Biovica International AB Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Biovica International AB's Operating Income for the three months ended in Jan. 2024 was kr-27.92 Mil. Biovica International AB's Revenue for the three months ended in Jan. 2024 was kr1.08 Mil. Therefore, Biovica International AB's Operating Margin % for the quarter that ended in Jan. 2024 was -2,597.12%.

Warning Sign:

Biovica International AB operating margin has been in a 5-year decline. The average rate of decline per year is -42.4%.

The historical rank and industry rank for Biovica International AB's Operating Margin % or its related term are showing as below:

OSTO:BIOVIC B' s Operating Margin % Range Over the Past 10 Years
Min: -3277.9   Med: -1784.26   Max: -282.89
Current: -1929


OSTO:BIOVIC B's Operating Margin % is ranked worse than
79.71% of 1025 companies
in the Biotechnology industry
Industry Median: -155.93 vs OSTO:BIOVIC B: -1929.00

Biovica International AB's 5-Year Average Operating Margin % Growth Rate was -42.40% per year.

Biovica International AB's Operating Income for the three months ended in Jan. 2024 was kr-27.92 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Jan. 2024 was kr-122.38 Mil.


Biovica International AB Operating Margin % Historical Data

The historical data trend for Biovica International AB's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biovica International AB Operating Margin % Chart

Biovica International AB Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Operating Margin %
Get a 7-Day Free Trial Premium Member Only -731.58 -1,784.26 -2,001.88 -2,997.51 -3,277.90

Biovica International AB Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3,216.52 -3,881.51 -1,835.23 -987.71 -2,597.12

Competitive Comparison of Biovica International AB's Operating Margin %

For the Biotechnology subindustry, Biovica International AB's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biovica International AB's Operating Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biovica International AB's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Biovica International AB's Operating Margin % falls into.



Biovica International AB Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Biovica International AB's Operating Margin % for the fiscal year that ended in Apr. 2023 is calculated as

Operating Margin %=Operating Income (A: Apr. 2023 ) / Revenue (A: Apr. 2023 )
=-110.924 / 3.384
=-3,277.90 %

Biovica International AB's Operating Margin % for the quarter that ended in Jan. 2024 is calculated as

Operating Margin %=Operating Income (Q: Jan. 2024 ) / Revenue (Q: Jan. 2024 )
=-27.919 / 1.075
=-2,597.12 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biovica International AB  (OSTO:BIOVIC B) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Biovica International AB Operating Margin % Related Terms

Thank you for viewing the detailed overview of Biovica International AB's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Biovica International AB (OSTO:BIOVIC B) Business Description

Traded in Other Exchanges
Address
Dag Hammarskjolds vag 54B, Uppsala Science Park, Uppsala, SWE, 752 37
Biovica International AB is a biotech company. It develops and commercializes blood-based diagnostic tests with biomarkers that improve monitoring and evaluation of modern cancer treatments. Through collaboration with world- leading cancer institutes and pharmaceutical companies, it promotes the trend in healthcare for personalized treatment, with a primary focus on patient survival and benefits to society. DiviTum is manufactured by the company and sold as a kit consisting of a reaction plate with reagents that have been optimized for ELISA applications.

Biovica International AB (OSTO:BIOVIC B) Headlines

No Headlines